Breaking News, Trials & Filings

Trials & Filings in Brief: Oct. 29, 2013

Ablynx, Alvine, Boehringer, Charleston, Innovus, Lumena, Merck, PharmaLink

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I Boehringer tests Ablynx Nanobody in AD . . . read more Merck presents interim NSCLC data for PD-1 inhibitor . . . read more Phase II Alvine begins celiac trial . . . read more Lumena begins PBC trial . . . read more Phase III Charleston ends painkiller trial early . . . read more Filings Innovus files EjectDelay in Canada . . . read more Pharmalink gets orphan status for Busulipo . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters